PIDD Mediates NF-κB Activation in Response to DNA Damage
- 1 December 2005
- Vol. 123 (6), 1079-1092
- https://doi.org/10.1016/j.cell.2005.09.036
Abstract
No abstract availableKeywords
Funding Information
- EMBO
This publication has 43 references indexed in Scilit:
- Inflammatory Diseases: Is Ubiquitinated NEMO at the Hub?Current Biology, 2004
- The two NF-κB activation pathways and their role in innate and adaptive immunityTrends in Immunology, 2004
- Active Repression of Antiapoptotic Gene Expression by RelA(p65) NF-κBMolecular Cell, 2004
- Modifiying NEMONature Cell Biology, 2004
- A Two-drug Model for Etoposide Action against Human Topoisomerase IIαJournal of Biological Chemistry, 2003
- SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoproteinProceedings of the National Academy of Sciences, 2001
- Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κBJournal of Clinical Investigation, 2001
- Topoisomerase II Is Required for Mitoxantrone to Signal Nuclear Factor κB Activation in HL60 CellsPublished by Elsevier ,2000
- CRM1 is responsible for intracellular transport mediated by the nuclear export signalNature, 1997
- Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nucleiNucleic Acids Research, 1983